written on 21.05.2014

Targeted Therapy in NSCLC Part III: VEGF / VEGFR


In the third in this series on targeted therapy in non small cell lung cancer (NSCLC) angiogenesis, or new vessel formation, represents a logical therapeutic target. Angiogenesis is necessary for malignant tumours to grow and to metastasize. The number of new vessels or endothelial cells within a tumour may be regarded as a morphological biomarker, […]